AMERICAN REGENT, INC.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1967-01-01
- Employees
- 501
- Market Cap
- -
Safety and Tolerability of 200mg and 100mg of Venofer Administered to Hemodialysis(HD) Patients
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 400
- Registration Number
- NCT06690450
Tralement vs. Fixed-dose Trace Element Combination Product in Patients >3 to 17 Years of Age Requiring Long-term PN
- Conditions
- Manganese Safety in Pediatric Patients
- Interventions
- Drug: Fixed-dose trace element combination product of zinc, copper, and selenious acid
- First Posted Date
- 2023-01-10
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT05677126
Tralement Versus a Fixed-dose Trace Element Combination Product to Evaluate Manganese Safety
- Conditions
- Manganese Safety in Adults
- Interventions
- Drug: Fixed-dose trace element combination product of zinc, copper, and selenious acid
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 108
- Registration Number
- NCT05661682
Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2023-01-06
- Lead Sponsor
- American Regent, Inc.
- Registration Number
- NCT04968379
- Locations
- 🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸Cohen Children's Medical Center, New Hyde Park, New York, United States
🇺🇸Nationwide Children's Hospital, Columbus, Ohio, United States
Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2022-03-21
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT04269707
- Locations
- 🇺🇸
South Florida Research Phase I-IV, Miami Springs, Florida, United States
🇺🇸Miami Clinical Research, Miami, Florida, United States
Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA
- Conditions
- Iron Deficiency Anemia
- Interventions
- First Posted Date
- 2018-05-14
- Last Posted Date
- 2022-06-22
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 79
- Registration Number
- NCT03523117
- Locations
- 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸International Research Partners, Inc., Doral, Florida, United States
🇺🇸ProHealth Research Center, Doral, Florida, United States
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study
- Conditions
- Iron-deficiencyHeart Failure
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 3065
- Registration Number
- NCT03037931
- Locations
- 🇺🇸
Advanced Cardiovascular LLC, Alexander City, Alabama, United States
🇺🇸Advanced Cardiovascular, LLC, Auburn, Alabama, United States
🇺🇸IMC/Diagnostic & Medical Clinic, Mobile, Alabama, United States
Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
- Conditions
- Restless Legs Syndrome (RLS)
- Interventions
- Drug: Placebo (Normal Saline)
- First Posted Date
- 2016-07-11
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT02826681
- Locations
- 🇺🇸
Synergy San Diego, Lemon Grove, California, United States
🇺🇸Alliance for Multispeciality Research, Fort Myers, Florida, United States
🇺🇸CNS Healthcare, Orlando, Florida, United States
Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy
- Conditions
- CalciphylaxisCalcific Uremic Arteriolopathy
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-08-18
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT02527213
- Locations
- 🇺🇸
Nephrology Consultants, Huntsville, Alabama, United States
🇺🇸Nephrology Association of Northern Indiana, Fort Wayne, Indiana, United States
🇺🇸A.A. Northeast Clinical Research Center, Bethlehem, Pennsylvania, United States
Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease
- Conditions
- Chronic Kidney Disease
- First Posted Date
- 2015-07-09
- Last Posted Date
- 2019-06-19
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT02492672
- Locations
- 🇺🇸
Stanford University, Palo Alto, California, United States
🇺🇸Nemours Orlando A.I. DuPont Hospital for Children, Jacksonville, Florida, United States
🇺🇸University of Miami, Miami, Florida, United States